Hypothesis

Simultaneous inhibition of the NLRP3 inflammasome in thymic myeloid cells and lactate dehydrogenase A (LDHA) in CD4+ T cells will produce a synergistic restoration of youthful immune function in aged mice, exceeding the additive benefits of each monotherapy.

Rationale

Aged thymic myeloid cells activate NLRP3 in response to lipotoxic cues, secreting IL-1β locally to drive cortical epithelial loss, naïve T cell depletion, and TCR repertoire narrowing 1. NLRP3 deficiency preserves thymic architecture and output up to 23 months 1. Peripherally, IL-6 promotes Th17 differentiation via STAT3‑dependent upregulation of Glut1 and LDHA, shifting metabolism toward glycolysis 3. LDHA blockade with FX11 selectively suppresses this pathogenic Th17 program while sparing Tregs 3. Notably, intrathymic IL-1β operates without detectable plasma elevation, indicating spatial separation from systemic IL‑6 signaling 1.

Because NLRP3‑derived IL‑1β and IL‑6‑driven glycolysis act in distinct compartments yet converge on immunosenescence, targeting both nodes may decouple the two pathways, allowing thymic regeneration while curbing peripheral inflammation.

Experimental Design

Model – C57BL/6 mice aged 18‑20 months.

Groups (n=10 per

Vascular Senescence as an Adaptive Signal for Intergenerational Resource Allocation

Background

The disposable soma and antagonistic pleiotropy frameworks explain age‑related vascular decline as a byproduct of selection waning after reproduction[1]2]3]. Yet the conservation of pathways such as mTOR, sirtuins and autophagy across taxa suggests they may be co‑opted for functions beyond simple damage accumulation[4]]5]. Recent work shows that senescent endothelial cells secrete a distinct SASP enriched in microRNA‑laden extracellular vesicles that can travel via the bloodstream to reproductive tissues[6].

Hypothesis

We propose that late‑life vascular senescence is not merely a neglected side effect but an evolved signaling mechanism that modulates offspring fitness by adjusting maternal resource allocation. Specifically, endothelial‑derived SASP factors act as circulating cues that reduce maternal investment in current reproduction, thereby favoring survival and investment in existing or future kin. This creates a feedback loop where vascular aging directly influences intergenerational trade‑offs, making it a selectable trait rather than a passive byproduct.

Mechanistic Reasoning

Hypothesis

Aging reprograms the selective autophagy machinery in colonic epithelial cells to favor degradation of soluble mismatch‑repair (MMR) proteins over damaged mitochondria, creating a permissive environment for mitochondrial field defects and spontaneous microsatellite instability that fuels field cancerization.

Mechanistic Rationale

• With age, lysosomal acidification declines and cytosolic NAD+ drops, altering the activity of autophagy receptors such as p62/SQSTM1 and NBR1 that recognize ubiquitin‑linked cargo.
• These receptors exhibit higher affinity for K63‑linked ubiquitin chains prevalent on MMR proteins under oxidative stress, whereas mitophagy receptors (e.g., BNIP3, NIX) rely more on phospho‑ubiquitin signals that become less accessible as mitochondrial membrane potential depolarizes.
• Consequently, under nutrient stress, autophagosomes sequester MMR proteins first, depleting their functional pool while damaged mitochondria persist, sustaining the COX‑deficient gradient observed in normal‑appearing mucosa.

Predictions

1. In colonocytes from donors >65 y, the ratio of MMR protein to TOMM20 within LC3‑II‑positive autophagosomes will be significantly higher than in donors <45 y under identical starvation conditions.
2. Acute inhibition of p62 will restore mitophagy precedence and increase mitochondrial clearance without affecting bulk autophagy flux.
3. Forced overexpression of a degradation‑resistant MMR variant (e.g., MLH1‑K->R ubiquitin‑site mutant) will mitigate age‑associated COX deficiency and reduce spontaneous microsatellite alterations in c

Hypothesis: Synchronizing Senolytic Clearance with Circadian Proteasome Peaks Enables Safe Conversion of Protective Aggregates into Degradable Substrates

Core Idea

We propose that the therapeutic window for senolytic drugs should be tightly coupled to the refeeding phase of time‑restricted eating, when fasting‑induced transcriptional programs boost proteasome capacity. In this window, senolytic‑mediated removal of senescent cells reduces the influx of new misfolded proteins, while the heightened proteasome activity can safely solubilize pre‑existing chaperone‑rich aggregates without generating toxic oligomers.

Mechanistic Reasoning

• Aggregate sequestration as a last‑resort order: In aged cells, persistent proteostasis stress drives the formation of amyloid‑like deposits that are enriched for HSP70/HSP90 chaperones, effectively locking away dangerous conformers (Protein aggregation as a protective mechanism).
• Risk of premature dissolution: Artificial disruption of these deposits before clearance systems are restored exposes hydrophobic patches that can sequester functional proteins, increasing proteotoxicity (PLOS Biology article).
• Senolytic‑driven autophagy boost: Senolytics activate AMPK/SIRT1 pathways, enhancing autophagic flux and reducing the burden of misfolded proteins that feed aggregate formation ([PMC12681496](https://pmc.ncbi.nlm.nih.gov/articles/PMC12681496/

Aging bone shows larger, more brittle hydroxyapatite (HA) crystals while dental apatite becomes smaller and more soluble. This divergence may stem from the opposite effects of undercarboxylated osteocalcin (ucOC) on HA nucleation in the two tissues. In bone, ucOC has low affinity for calcium‑rich crystal faces because its glutamic acid residues remain uncarboxylated, reducing its ability to block growth sites. Consequently, HA particles undergo Ostwald ripening, yielding larger crystals that impair mechanical adaptability【https://pubmed.ncbi.nlm.nih.gov/40794153/】. In dentin, the extracellular matrix contains phosphorylated proteins such as dentin sialophosphoprotein that preferentially bind ucOC, sequestering it away from HA surfaces. This local depletion of ucOC relieves its inhibitory effect on crystal growth, allowing other regulators (e.g., fetuin‑A) to promote finer, more soluble apatite【https://pmc.ncbi.nlm.nih.gov/articles/PMC2814098/】.

We hypothesize that the carboxylation state of osteocalcin acts as a molecular switch that tunes HA crystal size in a tissue‑dependent manner: high ucOC drives crystal enlargement in bone but promotes crystal refinement in dentin. This predicts three testable relationships: (1) bone biopsies from older adults with elevated serum ucOC will exhibit larger HA crystallite dimensions measured by X‑ray diffraction or transmission electron microscopy, whereas dentin samples from the same individuals will show smaller crystallites; (2) experimental increase of osteocalcin carboxylation via pharmacological vitamin K₂ (menaquinone‑7) supplem

Hypothesis\n\nCrocetin, after crossing the BBB, directly modulates HIF-1α stability in astrocytes by enhancing mitochondrial ROS scavenging and promoting prolyl hydroxylase domain protein 2 (PHD2) activity, leading to reduced HIF-1α accumulation under normoxia and a preconditioned hypoxic response that protects neurons during aging‑related metabolic stress.\n\n## Rationale\n\n1. Mitochondrial OXPHOS upregulation – Crocetin restores youthful OXPHOS gene expression and ATP generation in aged mice [1]. Improved electron transport reduces mitochondrial superoxide production, lowering ROS that inhibit PHD enzymes.\n2. ROS‑dependent PHD inhibition – Under oxidative stress, ROS oxidize Fe2+ in PHD active sites, suppressing HIF-1α hydroxylation and stabilising the factor [2]. By scavenging mitochondrial ROS, crocetin preserves PHD2 Fe2+ state, facilitating HIF-1α prolyl hydroxylation and VHL‑mediated degradation.\n3. Astrocytic specificity – Astrocytes exhibit high glycolytic flux and are major sensors of brain hypoxia; they also express elevated PHD2 relative to neurons [3]. Targeting astrocytes allows crocetin to fine‑tune interstitial HIF-1α levels, modulating VEGF and BDNF secretion without causing neuronal HIF‑1α‑driven maladaptive responses.\n4. Age‑dependent effect – Aged brains display basal mitochondrial ROS elevation and declining PHD2 activity [4]. Crocetin’s ROS‑scavenging capacity would therefore yield a larger relative increase in HIF-1α turnover in old versus young tissue, aligning with observed age‑stratified neuroprotective outcomes.\n5. Crosstalk with Nrf2 – Cr

Hypothesis

Senescent cells do not only secrete soluble SASP factors; they also actively remodel the extracellular matrix by upregulating lysyl oxidase (LOX), increasing collagen cross‑linking and tissue stiffness. This mechanical change alters integrin‑dependent signaling in infiltrating immune cells, shifting the balance between efficient phagocytic clearance and immune evasion. When LOX activity is high, the stiffened matrix suppresses immune cell activation and promotes a persistent, pro‑inflammatory senescent phenotype; when LOX is low, the matrix remains compliant, immune cells can effectively engage and eliminate senescent cells, allowing the transient "hostage negotiator" role to resolve.

Mechanistic Reasoning

• Senescent fibroblasts transiently express LOX as part of the SASP, a finding supported by proteomic analyses of SASP components[Senescent cells recruit immune cells via SASP for their own clearance while modulating local tissue environments].
• Increased matrix stiffness is known to dampen macrophage phagocytosis and skew cytokine production toward an immunosuppressive profile[Mechanical regulation of immune cell function].
• In acute wound healing, transient senescent cells deposit a pliable matrix that facilitates myofibroblast differentiation and repair[Topical PDGF‑AA application rescues healing in senescent‑cell‑depleted mice].
• Chronic accumulation of se

Hypothesis

Individuals with longer baseline REM latency require a higher dose of morning light (≥30 min outdoor light before 10 a.m.) to normalize sleep latency after evening screen exposure, whereas those with short REM latency achieve the same benefit with lower light doses.

Mechanistic Rationale

Evening screen use suppresses melatonin via melanopsin‑containing retinal ganglion cells, shifting the circadian phase later [https://www.health.harvard.edu/healthy-aging-and-longevity/blue-light-has-a-dark-side], [https://pmc.ncbi.nlm.nih.gov/articles/PMC3047226/]. The magnitude of this shift depends on the existing circadian timing, which is reflected in sleep architecture. REM latency—the interval from sleep onset to first REM episode—is inversely related to circadian phase advance capacity: longer REM latency indicates a later circadian phase and a reduced ability to advance the clock in response to light [https://academic.oup.com/sleep/article/46/Supplement_1/A256/7181854]. Morning light advances the sleep midpoint by suppressing melatonin and raising cortisol, an effect that scales with light duration and intensity [https://pmc.ncbi.nlm.nih.gov/articles/PMC12502225/]. Therefore, participants with longer REM latency start from a more delayed phase and need a larger photon input to achieve the same advance

Hypothesis\n\nA tissue‑specific epigenetic‑metabolic switch, mediated by HIF‑1α‑dependent DNA methylation at the HIF‑2α promoter, maintains hypoxic niche integrity in cardiac progenitor cells; loss of this switch triggers niche oxygenation, SASP‑driven paracrine senescence, and consequently manifests as the hallmarks of aging.\n\n### Mechanistic rationale\n- In hypoxic niches, HIF‑1α is stabilized and recruits the DNA methyltransferase DNMT3A to the promoter of HIF2A (EPAS1). Methylation suppresses HIF2A transcription, keeping HIF2A protein low. Low HIF2A limits ROS‑producing mitochondrial remodeling and sustains a quiescent, glycolytic phenotype in c‑Kit⁺ cardiac progenitor cells (CPCs).\n- With age, HIF‑1α activity declines due to reduced prolyl‑hydroxylase inhibition and increased NAD⁺ consumption, diminishing DNMT3A recruitment. Consequently, the HIF2A promoter becomes hypomethylated, HIF2A rises, drives a shift toward oxidative phosphorylation, elevates mitochondrial ROS, and perturbs the hypoxic microenvironment.\n- Elevated ROS activates NF‑κB in senescent CPCs, amplifying the SASP (IL‑6, IL‑8, MMPs). SASP factors diffuse to neighboring quiescent CPCs, inducing paracrine senescence and further eroding niche hypoxia—a positive feedback loop.\n- The resulting loss of quiescent CPC activation impairs regenerative capacity, leading to fibrosis, hypertrophy, and the classic hallmarks of aging (genomic instability, mitochondrial dysfunction, chronic inflammation, stem cell exhaustion).\n\n### Testable predictions\n1. ChIP‑qPCR in young mouse hearts will show HIF

Hypothesis

Age‑related mitochondrial dysfunction in adrenal cortical progenitor cells triggers zona reticularis senescence, leading to selective loss of DHEA(S) synthesis while sparing 11‑oxygenated androgen production.

Mechanistic Rationale

1. Mitochondrial ROS and senescence – Aging increases mitochondrial superoxide in the adrenal cortex, particularly in the zona reticularis where CYP17A1 activity generates electrophilic intermediates that can exacerbate oxidative stress【https://pmc.ncbi.nlm.nih.gov/articles/PMC10410302/】. Persistent ROS activates p16^INK4a^ and p21^Cip1^ pathways, driving a senescent phenotype that reduces progenitor proliferation and CYP17A1 transcription.

2. IL‑1β–mediated CYP17A1 suppression – Senescent zona reticularis cells secrete IL‑1β and other SASP factors. IL‑1β signaling through its receptor on neighboring progenitor cells suppresses CYP17A1 expression via NF‑κB‑dependent transcriptional repression, thereby lowering DHEA(S) output【https://pmc.ncbi.nlm.nih.gov/articles/PMC6741703/】. Importantly, the enzymes for 11‑oxygenated androgen synthesis (HSD3B2, SULT2A1) are less sensitive to IL‑1β, explaining their relative preservation.

3. Sex‑specific modulation – Androgen signaling in males promotes a pro‑inflammatory macrophage phenotype (M1) that amplifies IL‑1β release, accelerating zona reticularis senescence; estrogen in females favors an M2 phenotype that limits SASP, accounting for the more pronounced adrenal atrophy observed in older males【https://pmc.ncbi.nlm.nih.gov/articles/PMC10410302/】.

4. **Feedback loop with co

Hypothesis

Combining timed low-dose melatonin supplementation with morning blue-light exposure and early-time-restricted feeding (eTRF) will amplify the melatonin-NAD+-SIRT1 axis, thereby restoring circadian amplitude in middle-aged adults and improving healthspan biomarkers.

Mechanistic Rationale

Melatonin binds MT1/MT2 receptors, inhibiting adenylyl cyclase and lowering cAMP, which reduces protein kinase A (PKA) activity. Lower PKA diminishes phosphorylation of the NAD+-consuming enzyme CD38, leading to decreased NAD+ hydrolysis. Simultaneously, melatonin upregulates nicotinamide phosphoribosyltransferase (NAMPT), boosting the NAD+ salvage pathway. Elevated NAD+ activates SIRT1, which deacetylates core clock components BMAL1 and PER2, enhancing their transcriptional activity and reinforcing circadian oscillations. Morning blue-light advances the phase, increasing daytime alertness and boosting NAD+ production via circadian-driven NAMPT expression. Early TRF aligns nutrient intake with the active phase, further elevating NAD+ during SIRT1’s peak activity. Individuals carrying loss-of-function variants in MT1 (rs10830963) or MT2 (rs1387153) show blunted melatonin-mediated CD38 inhibition, predicting a genotype-dependent response.

Testable Predictions

1. Participants receiving the combined intervention will show a >=20% increase in nocturnal melatonin amplitude compared with baseline, exceeding the increase seen with either melatonin alone or blue-light alone.
2. NAD+/NADH ratio in peripheral blood mononuclear cells will rise by >=15% after 12 weeks, correlatin

Hypothesis

We propose that p21‑positive senescent glomerular endothelial cells act as transient chaperones that secrete a restricted SASP rich in tissue‑inhibitor of metalloproteinases‑1 (TIMP‑1) and lysyl oxidase‑like 2 (LOXL2), thereby stabilizing the glomerular basement membrane (GBM) and limiting podocyte detachment during the early phase of acute kidney injury (AKI). In contrast, p16‑positive senescent tubular epithelial cells amplify NF‑κB‑driven inflammation and promote maladaptive repair, contributing to fibrosis if they persist. Early senolytic ablation of p21+ endothelial senescence disrupts this protective ECM milieu, exacerbating GBM fragmentation and accelerating podocyte loss, whereas selective removal of p16+ tubular senescence attenuates inflammation and improves functional recovery.

Mechanistic Basis

• p21 induction in endothelial cells follows p53/TGF‑β signaling after sublethal ischemic stress, producing a SASP distinct from the classic pro‑inflammatory profile (see p21‑PAI‑1 podocyte loss mechanism).
• TIMP‑1 suppresses MMP‑2/9 activity, reducing collagen IV degradation, while LOXL2 promotes collagen cross‑linking, reinforcing GBM tensile strength.
• p16 elevation in tubular cells sustains RB‑CDK4/6 inhibition, locking cells into a stable arrest that sustains NF‑κB activation and IL‑1β/IL‑6/TNF‑α release (see p16 deletion protects against AKI).
• The temporal window: p21+ endothelial senescence peaks within 24‑48 h post‑injury, preceding the rise of p

Hypothesis

Progressive aging alters the H3K4me3/H3K27me3 ratio at bivalent promoters in a tissue‑specific manner, thereby switching the functional output of KDM5 and KDM6 histone demethylase isoforms from tumor‑suppressive to tumor‑promoting activities. This switch explains the paradoxical, context‑dependent roles of these enzymes in cancer and provides a mechanistic link between age‑associated epigenetic drift and chemotherapy resistance.

Rationale

• et al. show that KDM5A/B drive chemoresistance via DNA‑repair and mitochondrial pathways, whereas KDM5D can be tumor‑suppressive or resistance‑promoting depending on cancer type[1][2].
• KDM6A/B act as tumor suppressors in bladder cancer but promote colorectal cancer stemness through H3K27me3 demethylation[1][3].
• Bivalent promoters with a high H3K27me3:H3K4me3 ratio are more prone to DNA hypermethylation in cancer, and the ratio itself predicts epigenetic vulnerability[4].
• Chemotherapy‑induced loss of H3K27me3 at bivalent regions activates persister programs; timely KDM6 inhibition sustains the mark and reduces persisters[5].

Together, these observations suggest that the **balance of activating (H3K4me3) and repress

Hypothesis: Age‑associated copy‑number variations that enhance immune regulation (e.g., duplications of TLR1, PLAU, or PLGRKT) reduce mitochondrial DNA heteroplasmy load in hematopoietic stem and progenitor cells (HSPCs) by lowering chronic inflammatory signaling and reactive oxygen species (ROS) production, thereby attenuating clonal expansion of mtDNA mutants.

Mechanistic

rationale: Protective CNVs increase expression of innate immune receptors that promote anti‑inflammatory cytokine profiles (e.g., elevated IL‑10, reduced TNF‑α) in HSPCs. Lower inflammatory tone decreases NADPH oxidase activity and mitochondrial ROS, which are key drivers of mtDNA damage and heteroplasmy accumulation. Consequently, HSPCs carrying these CNVs experience a selective advantage for wild‑type mtDNA, slowing the age‑related rise in heteroplasmy observed after 70 years 4. This links the observed longevity benefit of immune‑regulatory CNVs in Alzheimer’s cohorts 2 to a cell‑autonomous mitigation of mitochondrial genomic instability.

Testable predictions: 1. In longitudinal blood samples from individuals >70 years, those with a protective CNV (validated by low‑pass WGS) will exhibit significantly lower mtDNA heteroplasmy fraction (measured by duplex sequencing) than CNV‑negative peers matched for age, sex, and ancestry. 2. CRISPR‑mediated introduction of a protective TLR1 duplication into human CD34⁺ HSPCs will reduce basal ROS (me

Hypothesis

Aged Paneth cell–derived Notum not only lowers Wnt ligands in the crypt base but also triggers a paracrine signal that activates mTORC1 in neighboring mesenchymal stromal cells, suppressing PPARα and inducing a senescence phenotype that further diminishes Wnt3 secretion. This creates a double‑negative feedback loop where mesenchymal senescence amplifies Wnt loss beyond the epithelial compartment, making simple Wnt restoration insufficient unless mesenchymal senescence is concurrently targeted.

Mechanistic rationale

• Notum removes palmitoleate from Wnt ligands, reducing their ability to bind Frizzled/LRP5/6 receptors.
• Loss of Wnt signaling in mesenchyme lowers β‑catenin activity, which normally represses p21^Cip1^ via transcriptional competition with FoxO factors; reduced β‑catenin lifts this brake, leading to p21 up‑regulation and senescence.
• Senescent mesenchymal cells secrete SASP factors (e.g., IL‑6, TGF‑β) that reinforce mTORC1 activation in Paneth cells, sustaining Notum expression.

Testable predictions

1. In aged mice, mesenchymal cells will show elevated p21^Cip1^ and γH2AX foci concurrent with increased Notum expression in Paneth cells.
2. Genetic ablation of senescence in mesenchymal stromal cells (e.g., p16^Ink4a^-positive cell clearance via INK‑ATTAC) will restore Wnt3 mRNA levels in the crypt base and improve organoid formation from aged ISCs, even without PPARα agonist treatment.
3. Pharmacologic inhibition of mTORC1 (rapamycin) in aged intestines will decrease Notum secretion from Paneth cells and reduce mesenchymal senescence mar

Hypothesis

Emodin, through its pan‑HDAC inhibitory activity, shifts the senescence‑associated secretory phenotype (SASP) of stressed glial and fibroblast cells from a pro‑inflammatory to a pro‑repair profile, thereby mitigating age‑related tissue dysfunction without clearing senescent cells.

Mechanistic Rationale

• Emodin suppresses EGFR/MAPK signaling, lowering Ras and ERK activity, which diminishes NF‑κB‑driven transcription of classic SASP cytokines such as IL‑6 and IL‑8 (Emodin suppresses M1 macrophage polarization...).
• As a fast‑on/slow‑off pan‑HDAC inhibitor, emodin increases histone acetylation at promoters of anti‑inflammatory SASP components (IL‑10, TGF‑β, VEGF) (Emodin acts as a pan‑HDAC inhibitor...).
• Acetylated chromatin favors binding of transcription factors like STAT3 and SMAD3, which are known to drive a reparative secretome when EGFR/MAPK tone is low (Emodin sensitizes cells to EGFR inhibitors by suppressing Stat3 signaling).
• The combined EGFR/MAPK dampening and HDAC inhibition creates a signaling milieu where senescent cells retain viability but secrete factors that promote angiogenesis, extracellular‑matrix remodeling, and microglial homeostasis rather than chronic inflammation.

Predictions & Experimental Design

1. In vitro SASP shift – Treat irradiated human microglia and fibroblasts with 10‑20 µM emodin for 24 h. Measure HDAC activity (fluorometric assay), acetyl‑H3/H4 levels (Western blot), and SASP

Mechanism

With age, cells experience progressive changes in nuclear lamina stiffness and chromatin organization that affect how DNA is released into circulation. In youth, the predominant source of plasma cfDNA is apoptotic nucleosomes trimmed by caspase‑activated DNase to ~166 bp, reflecting the protected nucleosome core. As lamin A/C accumulates and the nuclear envelope becomes more rigid, chromatin becomes less accessible to apoptotic nucleases, favoring alternative release pathways. Specifically, aging cells increase shedding of exosomes and microvesicles that encapsulate intact nucleosome‑protected DNA (~166‑170 bp) without enzymatic trimming. This shift results in a higher proportion of terminal cfDNA fragments that retain the canonical nucleosome size, while overall cfDNA concentration rises due to increased secretory activity.

The mechanistic link to methylation clocks lies in the fact that vesicular packaging preferentially preserves DNA from lamina‑associated domains (LADs) and heterochromatic regions, which are enriched for age‑related methylation changes (e.g., EPIC clock sites). Apoptotic trimming, by contrast, biases toward euchromatic, transcriptionally active regions that are less informative for epigenetic age. Consequently, the cfDNA methylation signal measured in plasma becomes a weighted average of two sources: (1) apoptotic, short‑fragment, euchromatic DNA (lower methylation age signal) and (2) vesicular, nucleosome‑length, heterochromatic DNA (higher methylation age signal).

Prediction

If this model is correct, then across the human lifespa

Hypothesis

We propose that age‑associated increases in cytoskeletal tension transmitted through the LINC complex alter nuclear mechanics, leading to stereotyped patterns of chromatin accessibility erosion and gain that are modulated by lamin A/C levels and YAP/TAZ activity. This mechanochemical feedback loop explains both the loss of stem‑cell identity signatures and the ectopic opening of lineage‑associated regulatory elements observed in aged HSCs, NSCs, and satellite cells, and predicts that normalizing nuclear tension will remodel the epigenome toward a youthful state irrespective of tissue origin.

Mechanistic Rationale

Aging stem cells exhibit elevated Rho/ROCK activity and increased actomyosin contractility, which we posit enhances force transmission via nesprin‑2 and SUN proteins to the nuclear lamina. Chromatin domains attached to the lamina experience tensile strain, promoting nucleosome sliding or histone eviction at lamina‑associated domains (LADs) – manifesting as accessibility erosion at stem‑cell identity loci. Simultaneously, tension‑induced chromatin decondensation at interior nuclear regions exposes distal enhancers, particularly those bound by mechanosensitive transcription factors such as MEF2C and AP‑1, driving the gain of progenitor‑associated signals. Lamin A/C, whose expression rises with age in many stem cell niches, stiffens the nucleus and amplifies this effect, whereas YAP/TAZ nuclear translocation acts as a tension‑sensitive co‑activator that stabilizes the opened state at MEF2‑motif–enriched regions observed in hippocampal NSCs.

Tes

Senescent cells maintain a stable SASP through early c‑Jun pioneer activity that remodels enhancers and later becomes resistant to JNK or mTOR inhibition [1][2]. We hypothesize that the irreversibility stems not from permanent chromatin marks but from a temporal mismatch: after the 72 h window, c‑Jun homodimers dominate AP‑1 complexes because defective ISR signaling prevents ATF4 synthesis, leaving no competitor for enhancer binding [3]. A brief, controlled pulse of mTOR activity—sufficient to restore ribosomal scanning and ATF4 translation without re‑engaging growth programs—should transiently increase ATF4‑containing AP‑1 dimers, allowing them to occupy c‑Jun‑primed enhancers and disrupt the positive feedback loop that sustains MKP5 suppression and oxidative stress [4][5].

Mechanistically, mTORC1 phosphorylates eIF2B and promotes eIF2α‑P dephosphorylation, relieving the translational block on ATF4 [6]. In senescence, chronic eIF2α‑P persists but ATF4 remains low due to impaired scanning. A short leucine or insulin pulse (15–30 min) would activate mTORC1, improve eIF2B activity, and permit a burst of ATF4 synthesis. ATF4 can then form heterodimers with c‑Jun or JunD, competing for the same AP‑1 sites established by pioneer c‑Jun. Because these enhancers are still accessible (they are n